![Maria Alba](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Maria Alba worked as Global Medical Leader at Amicus Therapeutics, Inc. Dr. Alba worked as Vice President-Clinical Research at Immunovant, Inc. from 2022 to 2026.
Dr. Alba earned a doctorate from The Catholic University of America.
Anciens postes connus de Maria Alba
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOVANT, INC. | Directeur Technique/Scientifique/R&D | 31/03/2026 |
| AMICUS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Maria Alba
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
The Catholic University of America
 The Catholic University of America Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
